- Home
- Genetic Disease
- Pharmacological Management of Hutchinson-Gilford Progeria Syndrome (HGPS)

1mo3 min read
Medical Article
Hutchinson-Gilford Progeria Syndrome (HGPS) is a rare and fatal genetic disorder resulting from a de novo mutation in the LMNA gene, which causes the production of progerin, an abnormal and toxic form of lamin A. Progerin accumulates in the nuclear envelope, leading to structural instability, impaired DNA repair, and premature cellular senescence.

Pharmacological Management of Hutchinson-Gilford Progeria Syndrome (HGPS)
5 Reached
Similar Content

Atypical Cellular Blue Nevus in a woman
93 Reached4 Comments1 Likes

Chronic Cough in Adolescent
282 Reached1 Comments6 Likes

Paclitaxel for Management of Breast Cancer
69 Reached4 Comments

Total Hip Arthroplasty in a Patient with Congenital Insensitivity to Pain
358 Reached4 Comments5 Likes

Reviving Malaysia's Medical Tourism
943 Reached3 Comments